Skromne-Kadlubik G, Hidalgo RR

Language: Spanish
References: 3
Page: 75-76
PDF size: 46.73 Kb.

ABSTRACT

We labell the Vascular Endothelial Growth Factor (VEGF) with gamma and betta emisors; and approved in radiocrhomatography and Radiofharmaceutical tests. With this new radiopharmaco we take scans of 12 patients with endometriosis and give treatment in six selected cases without adverse reactions or intolerance in six months of follow-up. Because of the encorageous results and the harmless and simple technic, we propose the VEGF, radiactive for the diagnoses and treatment of a difficult disease that is the endometriosis today.

REFERENCES

1. Murphy A. Clinical aspects of endometriosis. Ann N.Y. Acad. Ciences 1; 2002: 955.

2. Yen SSC, et al. (eds). Reproductive Endocrinology. 5th. Ed. Philadelphia, Saunders. 1999, Cap II.

3. Skromne-Kadlubik G, Hidalgo R. Factor del crecimiento nervioso. Com. Salud. Vol. II (32); Nov.-Dic. 1998; 49-52.